BackAlamar Biosciences Overview
Alamar Biosciences, Inc.

Alamar Biosciences Target Price

See Alamar Biosciences's analyst price targets ($32) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$32.92

Average Target Price

$31.504.3% downside

2 analysts in the last 4 months

High: $35 | Low: $28

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-12Leerink Partners$356.3% upsideOpen
2026-05-12Stifel Nicolaus$2814.9% downsideOpen

Alamar Biosciences (ALMR) FAQ

As of the most recent data, ALMR shows a target price of $32. Scroll down for historical charts and peer comparison views.

If Alamar Biosciences moved to the average analyst target of $32, shares would be roughly 4.3% lower than $32.92. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Alamar Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Alamar Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $32) with ownership activity and broader fundamentals.

Alamar Biosciences's target price is $32; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.